Dr. Reddy's Laboratories Shows Resilience Amid Mixed Market Trends and Valuation Insights
Dr. Reddy's Laboratories is actively trading at Rs 1261.95, reflecting a slight increase today. With a market capitalization of Rs 1,05,128.00 crore and a P/E ratio of 18.59, the stock shows a mixed short-term momentum. Over the past year, it has declined 4.66%, but gained 8.85% in the last three months.
Dr. Reddy's Laboratories, a prominent player in the Pharmaceuticals & Biotechnology sector, has shown notable activity today, trading at Rs 1261.95. The stock's performance aligns with the sector, reflecting a slight increase of 0.56% for the day, while the broader Sensex experienced a minor decline of 0.03%. With a market capitalization of Rs 1,05,128.00 crore, Dr. Reddy's Laboratories maintains a price-to-earnings (P/E) ratio of 18.59, significantly lower than the industry average of 36.55, indicating a potentially favorable valuation relative to its peers.
In terms of moving averages, the stock is currently above the 5-day, 100-day, and 200-day averages, although it remains below the 20-day and 50-day averages, suggesting mixed short-term momentum.
Over the past year, Dr. Reddy's Laboratories has faced a decline of 4.66%, contrasting with the Sensex's positive performance of 2.35%. However, the stock has shown resilience in the short term, with an 8.85% increase over the last three months, outperforming the Sensex's 5.17% gain during the same period.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
